Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT03495583
Other study ID # GN2551
Secondary ID
Status Enrolling by invitation
Phase N/A
First received April 4, 2018
Last updated April 4, 2018
Start date April 3, 2018
Est. completion date April 2021

Study information

Verified date March 2018
Source King's College London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The EAT Study showed a reduction in both sensitisation (to all foods) and clinical food allergy (to peanut and egg) among children who consumed allergenic food early compared with those who followed standard government feeding advice to exclusively consume breast milk for the first 6 months of life. The EAT-On Study aims to establish whether the effects seen at 3 years in the EAT study represent a delay in FA onset or sustained tolerance. EAT-On will also investigate the natural history (emergence and resolution) of FA in childhood; thus shaping dietary and management plans for allergic patients. Findings will inform future research and weaning recommendations for preventing FA.


Description:

Sensitisation/Allergy:

Food allergy (FA) is common, increasing in prevalence and represents a public health concern in many countries. FA increasingly affects geographic regions where rates of FA were previously low.(1-5) Data from the Enquiring About Tolerance (EAT) study, which enrolled 1303 exclusively breastfed three month old babies from the general population, showed that 8% of children had proven immediate-onset FA at three years of age. This equates to almost 1 in 10 children. (1) The early-introduction of specific food allergen(s) to infant diets is a successful strategy for the prevention of FA. Introduction of peanut to the infant diet before 11 months of age, protected against the development of peanut allergy in a high-risk, atopic population.(6) This effect persisted despite cessation of peanut consumption for 12 months.(7) In the EAT Study, children from the general population were randomised either to consume six commonly allergenic foods (cow's milk, egg, peanut, wheat, fish and sesame) from four months of age (early introduction group (EIG)), or to follow Department of Health (DoH) advice to exclusively breastfeed until about 6 months of age (standard introduction group (SIG)). The per-protocol analysis revealed a reduction in any FA of 7.3% versus 2.4% (p=0.01), for peanut allergy of 2.5% versus 0% (p=0.003) and for egg allergy 5.5% versus 1.4% (p=0.009) in the SIG and EIG respectively. (8) In the EAT study, between 1 and 3 years an intention-to-treat analysis (ITT) of sensitisation to individual foods showed a significant cumulative treatment effect of 35% (p=0.0095) in the EIG (unpublished data). Furthermore, in the per-protocol analyses (PP), we showed a statistically significant reduction of 41.6% (p=0.01) in skin prick test (SPT) sensitivity to any food at 1 year, and again at 3 years with a 67.3% relative reduction (RR) (p=0.002) in the EIG. These findings were particularly significant for individual food; at 3 years there was a relative reduction in skin-prick sensitivity to all individual foods and particularly for peanut (RR 67.1% p=0.007).

FA is a dynamic condition with egg and milk allergy typically developing in infancy and being outgrown and peanut and sesame allergy usually developing between the ages of 3-6 and persisting into adulthood. Whilst early introduction of commonly allergenic foods is effective in preventing food allergy in early childhood and within the confines of a randomised controlled trial (RCT), the longevity of this novel approach has not been tested and little is known about whether these effects are sustained after 'real world' ad libitum consumption. The EAT-On Study aims to investigate this by following-up children who were previously enrolled in the EAT Study when they are 8 years of age and investigating the natural history of food allergy, and how the intervention that was applied when children were 4-6 months of age influences food allergic sensitisation and clinical food allergy when they are 8 years of age.

Child Health:

Whilst the UK Department of Health recommends exclusive breastfeeding (EBF) until around six months of age, surveys suggest this is achieved by only 1% of mothers(9). Given the lack of EBF till 6 months of age, the majority of infants will require additional nutrition provided from formula and/or solid weaning foods. Indeed, 75% of infants have been introduced to solid food by 5 months of age (9). The nutritional consequences of different weaning regimens may have important consequences on obesity outcomes, but rigorous trials in this area are difficult to undertake, not least because of the necessary ethical concerns that pertain to the comparison of breast-feeding with alternate or complementary feeding strategies. The EAT cohort presents a unique opportunity to study this question further as the diet consumed by children who participated in the EIG of the EAT study is much higher in protein than breastmilk alone. Good quality studies have found that consumption of high protein formula milk in early infancy increases the risk of overweight in later childhood compared with breastfeeding, but the effect of high protein solid food consumption alongside breastfeeding in early infancy has not been studied. The majority of infants have solid food introduced before 6 months of age, and updated guidance advocates the introduction of a high protein food (peanut) from 'around 6 months of age' (UK(10) and Australia(11)), or at 4 months of age (USA(12)) to prevent a new onset of peanut allergy. It is therefore timely to explore how early diet, particularly with respect to high protein weaning diet, influences childhood obesity. This will lead to the development of clearer guidance in respect to early weaning diet which extends to other high protein foods, while taking in to account the risk of childhood obesity.

The nature of the EAT cohort means that between 4 and 6 months of age children were randomised either to a lower protein diet (SIG) or to a higher protein diet (EIG): breastmilk contains approximately 6% energy from protein whilst the EIG were asked to consume a diet containing at least 15% energy from protein, more than double that of the SIG. This cohort therefore offers a unique opportunity to explore the effect of differing energy consumption from dietary protein on overweight/obesity and markers of cardiovascular health in later childhood.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 1235
Est. completion date April 2021
Est. primary completion date April 2021
Accepts healthy volunteers No
Gender All
Age group 7 Years to 8 Years
Eligibility Inclusion Criteria:

- Previous participation in the EAT study

- Age 8 years +/- 12 months

Exclusion Criteria:

Study Design


Intervention

Other:
Early introduction
Consumption of 2g/week of cow's milk, hen's egg, wheat, peanut, sesame and fish protein from 3 months of age (alongside breastfeeding)

Locations

Country Name City State
United Kingdom Paediatric Allergy London

Sponsors (2)

Lead Sponsor Collaborator
King's College London Action Medical Research

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Allergic sensitisation Between group differences in total number of cumulative sensitisations to the six study food allergens at age 8 3 years
Primary Food allergy Between group differences in cumulative food allergy (challenge confirmed) t the six study foods at age 8 3 years
Primary Child Health Between group differences in proportion of children who classified as overweight or obese as determined by their BMI and/or BMI z score 3 years
Secondary Other allergic sensitisations Between group differences in proportion of children with SPT sensitisation to additional food allergens (hazelnut, brazil nut, cashew, almond and walnut) and aero-allergens (timothy grass, birch pollen, house dust mite, cat and dog dander). 3 years
Secondary Mechanisms of allergy Between group differences in specific IgE, IgG and IgG4 to peanut, egg, sesame and aeroallergens 3 years
Secondary Coeliac disease Between group differences in prevalence of coeliac disease using coeliac antibody test (tTG IgA) screening test 3 years
Secondary Atopic dermatitis Between group differences in prevalence of atopic dematitis 3 years
Secondary Allergic rhinoconjunctivitis Between group differences in prevalence of seasonal and perennial rhinoconjunctivitis 3 years
Secondary Asthma Between group differences in prevalence of asthma 3 years
Secondary Oral allergy syndrome Between group differences in prevalence of oral allergy syndrome 3 years
Secondary Parent reported food allergy Between group differences in food reaction history (parent-reported immediate onset food allergy) 3 years
Secondary Sibling allergies Prevalence of sibling allergies (food allergies, eczema, asthma and rhinitis) 3 years
Secondary AGE Level in association with food allergies Between group differences in AGE levels in association with food allergies 3 years
Secondary Skin fold thickness Between group differences in skin fold thickness (triceps and subscapular) 3 years
Secondary Circumference measurements Between group differences in midarm, waist and head circumference 3 years
Secondary Anthropometric ratios Between group differences in; adjusted weight for height; waist; height ratio; height adjusted weight circumference 3 years
Secondary Fat free mass Between group differences in fat free mass 3 years
Secondary Conicity index Between group differences in conicity index (calculated from waist circumference and height and weight measurements) 3 years
Secondary Cardiovascular health Between group differences in the proportion of children with cardiovascular measurements outside the expected range 3 years
Secondary Vascular stiffness Between group differences in vascular stiffness 3 years
Secondary AGE Between group differences in advanced glycation end products (AGE) 3 years
Secondary Inflammation Between group differences in inflammation (measured using IL=6; sensitive CRP; TNF alpha; MCP-1; RANTES chemokine 3 years
Secondary Metabolic and endocrine Between group differences in insulin, IGF-1 and leptin 3 years
Secondary White cell count Between group differences in total white blood cell count 3 years
Secondary Macronutrient dietary intake Between group differences in macronutrient intake 3 years
Secondary Dietary habits Between group differences in fussy eating 3 years
Secondary Physical activity Influence of physical activity on anthropometry and body composition measurements 3 years
Secondary Genetic influences Influence of parental size on: height; weight; waist circumference on participant's size 3 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Active, not recruiting NCT06259539 - A YouTube Curriculum for Children With Autism and Obesity N/A
Completed NCT03533621 - Gut Microbiome, Adiposity, and Probiotics (GMAP) N/A
Completed NCT03641521 - A Trial to Increase Child Vegetable Intake Through Behavioral Strategies N/A
Completed NCT04009304 - Effective Training Models for Implementing Health-Promoting Practices Afterschool N/A
Completed NCT05563311 - Functional Assessment and Sleep Apnea in Obese Children and Adolescents N/A
Completed NCT03575884 - Fit 5 Kids Screen Time Reduction Curriculum for Latino Preschoolers N/A
Terminated NCT03586544 - Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity Phase 4
Completed NCT04628897 - Physical Activity and the Home Environment in Preschool-aged Children in Urban Bangladesh
Completed NCT03399617 - SPOON: Sustained Program for Improving Nutrition - Guatemala N/A
Enrolling by invitation NCT06265597 - The Effect of Healthy Nutrition and Yoga Program on Obese Children N/A
Active, not recruiting NCT03843424 - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers N/A
Completed NCT03170700 - Online Videos and New Feeding Content to Enhance a Current EFNEP Program N/A
Not yet recruiting NCT06464497 - Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity N/A
Enrolling by invitation NCT05551650 - El Sendero: Pathways to Health Study
Completed NCT04346433 - Sleep and Stigma: Novel Moderators in the Relationship Between Weight Status and Cognitive Function N/A
Recruiting NCT03963557 - Cognitive Function and Body Mass Index in Children and Adolescents
Completed NCT03495310 - Effect of Mindfulness on Stress, Appetite Hormones and Body Weight of Obese Schoolchildren. Controlled Clinical Trial N/A
Recruiting NCT06028113 - A Novel Obesity Prevention Program for High-Risk Infants in Primary Care Phase 2
Active, not recruiting NCT05465057 - "HIIT Med Kiloene". N/A